Drug profile · INN
mazindol
SANOREX
mazindol (SANOREX) is a monoamine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — mazindol
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
mazindol (SANOREX) is a monoamine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Monoamine transporter inhibitor
Primary target: Monoamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is mazindol?
mazindol (SANOREX) is a monoamine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for mazindol?
SANOREX is a marketed brand name for mazindol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mazindol?
mazindol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.